Rocket Lab's shares have fallen 33% recently despite gains in defense contracts, the transformative acquisition of Iridium, and progress with its Neutron rocket commercialization. The company is diversifying beyond launch services into defense programs and vertical integration, with Neutron now a key driver for future profitability and cash flow. However, rising global competition, highlighted by China's reusable rocket advancements, pressures Rocket Lab to execute well to justify its high valuation near 30 times forward sales. The focus now shifts to execution rather than hype as the market adjusts post-SpaceX IPO.
Rocket Lab Corporation announced it will publish its second quarter 2026 financial results on August 10, 2026, after U.S. market close. The company will hold a conference call at 2:00 p.m. Pacific Time to discuss the results, accessible via webcast o...
Iridium Communications was upgraded to a Buy rating by New Street following its Q2 2026 earnings report, which showed a 3.8% revenue increase to $225.24 million, beating estimates. However, its EPS of $0.19 missed analyst expectations. The upgrade al...
Rocket Lab secured a $266 million contract from the US Air Force and Space Force to conduct 12 suborbital launches, with options for six more. The launches will operate from Alaska's Pacific Spaceport Complex and are expected to finish by the end of ...
David H. Lerner remains optimistic about the stock market, focusing on aerospace, defense, biotech, AI, and semiconductors like Micron and Nvidia, which he views as undervalued despite recent sector sell-offs. He highlights supportive factors such as...
